Centrul Medical Dr. Ianosi
- Address
- lock Available on a paid plan
Centrul Medical Dr. Ianosi - Dermatology Research Center
Centrul Medical Dr. Ianosi is a specialized clinical research facility focused on advancing dermatological treatments, with particular expertise in immune-mediated skin conditions. The center participates in pivotal Phase 3 clinical trials evaluating innovative therapies for patients with moderate to severe plaque psoriasis, contributing to the development of next-generation treatment options.
- Novel biologic and systemic therapies for plaque psoriasis
- Long-term safety and efficacy evaluation of dermatological treatments
- Comparative effectiveness studies with active and placebo controls
The research center's involvement in both initial efficacy studies and extended follow-up trials demonstrates its commitment to comprehensive patient care and rigorous assessment of treatment durability and long-term tolerability. This longitudinal approach ensures that participating patients receive continuous monitoring while contributing valuable data on sustained therapeutic responses in chronic inflammatory skin diseases.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Can-Fite Biopharma Ltd.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Alumis Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centrul Medical Dr. Ianosi
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Namodenoson in Patients with Non-Alcoholic Steatohepatitis (NASH) with F1-3 Fibrosis: A Phase 2B Randomized, Double-Blind, Placebo-Controlled Study | Can-Fite Biopharma Ltd. | Phase II | Recruiting | Mar 2023 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Envudeucitinib | 2 | Unknown | 2025-02-20 | 2025-06-13 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.